Table 3.
Clinical features in patients with active morphea; values expressed as mean (SEM) unless otherwise specified
| Pediatric-onset | Adult-onset | P value | |
|---|---|---|---|
| Number of patients | 21 | 144 | |
| Visit age | 20.3 (1.0) | 49.7 (1.3) | <0.0001 |
| Age of onset | 11.9 (0.9) | 45.8 (1.4) | <0.0001 |
| Disease duration | 8.5 (1.7) | 3.9 (0.4) | 0.0005 |
| MRSS, number scored | 21 | 142 | |
| MRSS score | 6.6 (1.3) | 7.0 (0.5) | 0.81 |
| LoSCAT, number scored | 21 | 144 | |
| mLoSSI | 11.1 (2.9) | 20.2 (1.9) | 0.07 |
| LoSDI | 17.5 (3.6) | 18.5 (1.4) | 0.8 |
| PGA-A | 27.7 (4.7) | 44.6 (2.4) | 0.01 |
| PGA-D | 47.1 (5.6) | 28.5 (1.7) | 0.0003 |
| Functional impairment, n (%) | 8 (38) | 34 (24) | 0.18 |
| Deep involvement, n (%) | 15 (71) | 74 (51) | 0.1 |